MKM Partners Raises Price target on Lululemon Athletica (LULU) Following 4Q Conference Call

Oppenheimer Raises Price Target on Lululemon Athletica (LULU) Following Strong 4Q

March 31, 2016 8:53 AM EDT

Oppenheimer reiterated an Outperform rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target to $80.00 (from $70.00), following the company's 4Q earnings report. LULU's holiday results were better across the board, with 11% comp 7-point acceleration on 2-year stack, gross margins exceeding high end of guided range and inventory reduction... More

The New Lulemon Athletica (LULU) - Cowen

March 31, 2016 8:37 AM EDT

Cowen analyst, Oliver Chen, raised his PT on shares of Lululemon Athletica Inc. (NASDAQ: LULU) to $76 (from $66) as strong +11% 4Q comps on traffic & ticket prices makes the business now feel stable w/talent & product innovation. No change to Outperform rating.

LULU reported 4Q EPS of 85c, ahead of the Street at 80c. Most encouraging was the better-than-expected comp of +11% (incl. DTC), which came in ahead of the Street at +8%. The +11% comp was... More

UBS Raises Price Target on Lululemon Athletica (LULU) Following a Strong 4Q Report

March 31, 2016 7:57 AM EDT

UBS reiterated a Neutral rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target to $69.00 (from $60.00), following the company's 4Q earnings report. LULU reported an SSS & EPS beat, while simultaneously beating GM's and reducing inventories a quarter early.

Analyst Michael Binetti commented, "We're impressed that LULU achieved a SSS & EPS beat while... More

Wedbush Raises Price Target as lululemon athletica (LULU) Sets 2020 Targets

March 31, 2016 7:36 AM EDT

Wedbush reiterated an Outperform rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target to $80.00 (from $72.00), following the company's 4Q earnings report. 4Q easily topped expectations, with SSS hitting +11% versus raised guidance of +HSD. Momentum has continued into 1Q, though executives... More

Nomura Securities Raises Price Target on lululemon athletica (LULU) Following 4Q and Long Term Outlook

March 31, 2016 7:11 AM EDT

Nomura Securities reiterated a Buy rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target to $72.00 (from $59.00), following the company's 4Q earnings report. LULUs 11% comp surpassed St estimates and remains an industry leader. Beyond the standard +1Q/+1FY guide,... More

Mizuho Securities Raises Price Target on lululemon athletica (LULU) Following 4Q Beat

March 30, 2016 4:33 PM EDT

Mizuho Securities reiterated a Neutral rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target of $65.00 (from $50.00), following the company's 4Q. LULU reported EPS of $0.85 vs. $0.78 LY, above the consensus estimate of $0.80 on comps of +11% vs. +8% LY. Management also stated that it... More

Sterne Agee CRT Reiterates Buy on lululemon athletica (LULU) Following 4Q Earnings and Guidance

March 30, 2016 3:52 PM EDT

Sterne Agee CRT maintained a Buy rating and $75.00 price target on Lululemon Athletica Inc. (NASDAQ: LULU) following the company's 4Q. Total SSS on an FX-neutral basis increased 11% with brick & mortar SSS +5% and e-commerce sales +33%. LULU reported adjusted EPS of $0.85 versus guidance of $0.78-$0.80. 1Q16 EPS guidance of $0.28-$0.30 on... More

Pre-Open Stock Movers 03/30: (ACAD) (VICL) (ANTM) Higher; (CTRV) (VRNT) (LNDC) Lower (more...)

March 30, 2016 9:36 AM EDT

ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) 23.4% LOWER; announced the pricing of a best efforts underwritten public offering of up to 4,929,578 shares of its common stock and warrants to purchase up to 2,464,789 shares of the Company's common stock at a fixed combined... More

Slowdown in Comps Hits lululemon's (LULU) Q4 Results, Outlook; FBR Affirms at 'Underperform'

March 30, 2016 9:00 AM EDT

FBR & Co. affirms lululemon athletica (Nasdaq: LULU) at Underperform following Q4 results and outlook issued earlier Wednesday.

Analyst Susan Anderson noted the following points today ahead of the company's quarterly conference call:

4Q results. 4Q adjusted EPS of $0.85 reflected (1) comps of +11% (vs. FBR/street of +7.5%/+8.1%); (2) SG&A... More

Cowen Remains Bullish on lululemon athletica (LULU) Following Strong 4Q Results

March 30, 2016 8:53 AM EDT

Cowen reiterated an Outperform rating and $66.00 price target on Lululemon Athletica Inc. (NASDAQ: LULU) following the company's 4Q earnings report. LULU reported 4Q EPS of $0.85, higher than the Street at $0.80, & vs. management's guidance of $0.78-$0.80. The result was driven by a higher-than-anticipated sales, a... More

lululemon athletica (LULU) Tops Q4 EPS by 5c; Guides Q1 EPS Below Expectations

March 30, 2016 6:04 AM EDT

lululemon athletica (NASDAQ: LULU) reported Q4 EPS of $0.85, $0.05 better than the analyst estimate of $0.80. Revenue for the quarter came in at $704.3 million versus the consensus estimate of $693.38 million.

Total comparable sales, which includes comparable store sales and... More

Trading Radar for 3/30: lululemon athletica (LULU), Carnival (CCL), Paychex (PAYX), Progress Software (PRGS) Report

March 29, 2016 3:04 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EDT

MBA Mortgage Index - no Street consensus

8:15am EDT

ADP Employment Change - Street sees 196k

Earnings:

Affimed (Nasdaq: AFMD) - consensus loss $0.18
Akers Biosciences (Nasdaq: AKER) - no Street consensus
Aldeyra Therapeutics... More

FBR Capital Highlights Short lululemon athletica (LULU) Ahead of Earnings

March 29, 2016 2:09 PM EDT

FBR Capital Alpha Generator highlights a short lululemon athletica (NASDAQ: LULU) call ahead of earnings due tomorrow.

The firm commented: "FBRs bear view on LULU consists of near-term and long-term catalysts that we believe will drive LULUs already high valuation (trades at 28x FY2) down. Our near- and long-term view is based on our proprietary... More

UBS Remains Sidelined Ahead of lululemon athletica's (LULU) 4Q Report

March 29, 2016 7:41 AM EDT

UBS reiterated a Neutral rating and $60.00 price target on Lululemon Athletica Inc. (NASDAQ: LULU) ahead of the company's 4Q earnings report. LULU's inventory growth of 56% vs +15% rev guidance for 4Q suggests that inventories are too high by ~$90-$95ma small amount considering mkt cap is down by $1B+ since inventory... More